Home/Pipeline/MINT®

MINT®

Openaucoma (IOP reduction)

CE marked, commercialActive

Key Facts

Indication

Openaucoma (IOP reduction)

Phase

CE marked, commercial

Status

Active

Company

About Sanoculis

Israeli medtech firm delivering stent‑free minimally invasive glaucoma surgery devices.

View full company profile

Therapeutic Areas